Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Luca Castagna

Showing results (11-20 of 203) with videos related to

Pageof 21
Sort By:
Cancer Chemotherapy and Biological Response Modifiers|August 23, 2005
LymphomasArmando Santoro, Luca Castagna, Massimo Magagnoli
Transplantation and Cellular Therapy|October 5, 2020
Acute Graft-versus-Host-Disease Other Than Typical Targets: Between Myths and FactsJacopo Mariotti, Olaf Penack, Luca Castagna
Journal of Blood Medicine|November 5, 2020
Salvage Therapy for Hodgkin's Lymphoma: A Review of Current Regimens and OutcomesLuca Castagna, Armando Santoro, Carmelo Carlo-Stella
The Oncologist|October 13, 2004
Low-dose warfarin prophylaxis for catheter-associated thrombosis in cancer patients. Can it be safely associated with 5-Fluorouracil-based chemotherapy?Massimo Magagnoli, Luca Castagna, Giovanna Masci, et al.
British Journal of Haematology|September 15, 2007
Rituximab in thrombotic microangiopathyLuca Castagna, Elisabetta Todisco, Barbara Sarina, et al.
Journal of Clinical Medicine|November 11, 2020
Haploidentical Stem Cell Transplantation in Lymphomas-Expectations and PitfallsJacopo Mariotti, Stefania Bramanti, Armando Santoro, et al.
Experimental Hematology|November 21, 2017
T-cell-replete haploidentical transplantation in acute myeloid leukemiaLuca Castagna, Raynier Devillier, Norbert Vey, et al.
Mediterranean Journal of Hematology and Infectious Diseases|March 7, 2015
Current role of autologous and allogeneic stem cell transplantation for relapsed and refractory hodgkin lymphomaLuca Castagna, Carmelo Carlo-Stella, Rita Mazza, et al.
Current Stem Cell Research & Therapy|January 29, 2008
What is the best option to cure patients with resistant/relapsing Hodgkin's disease?Massimo Magagnoli, Monica Balzarotti, Luca Castagna, et al.
Leukemia & Lymphoma|September 4, 2003
High-dose chemotherapy supported by peripheral blood stem cell transplantation in elderly versus younger lymphoma patients: a matched analysisMassimo Magagnoli, Luca Castagna, Inna Timofeeva, et al.
Pageof 21

Showing results (11-20 of 203) with videos related to

Sort By:
Pageof 21
Cancer Chemotherapy and Biological Response Modifiers|August 23, 2005
LymphomasArmando Santoro, Luca Castagna, Massimo Magagnoli
Transplantation and Cellular Therapy|October 5, 2020
Acute Graft-versus-Host-Disease Other Than Typical Targets: Between Myths and FactsJacopo Mariotti, Olaf Penack, Luca Castagna
Journal of Blood Medicine|November 5, 2020
Salvage Therapy for Hodgkin's Lymphoma: A Review of Current Regimens and OutcomesLuca Castagna, Armando Santoro, Carmelo Carlo-Stella
The Oncologist|October 13, 2004
Low-dose warfarin prophylaxis for catheter-associated thrombosis in cancer patients. Can it be safely associated with 5-Fluorouracil-based chemotherapy?Massimo Magagnoli, Luca Castagna, Giovanna Masci, et al.
British Journal of Haematology|September 15, 2007
Rituximab in thrombotic microangiopathyLuca Castagna, Elisabetta Todisco, Barbara Sarina, et al.
Journal of Clinical Medicine|November 11, 2020
Haploidentical Stem Cell Transplantation in Lymphomas-Expectations and PitfallsJacopo Mariotti, Stefania Bramanti, Armando Santoro, et al.
Experimental Hematology|November 21, 2017
T-cell-replete haploidentical transplantation in acute myeloid leukemiaLuca Castagna, Raynier Devillier, Norbert Vey, et al.
Mediterranean Journal of Hematology and Infectious Diseases|March 7, 2015
Current role of autologous and allogeneic stem cell transplantation for relapsed and refractory hodgkin lymphomaLuca Castagna, Carmelo Carlo-Stella, Rita Mazza, et al.
Current Stem Cell Research & Therapy|January 29, 2008
What is the best option to cure patients with resistant/relapsing Hodgkin's disease?Massimo Magagnoli, Monica Balzarotti, Luca Castagna, et al.
Leukemia & Lymphoma|September 4, 2003
High-dose chemotherapy supported by peripheral blood stem cell transplantation in elderly versus younger lymphoma patients: a matched analysisMassimo Magagnoli, Luca Castagna, Inna Timofeeva, et al.
Pageof 21